Eugene Shildkrot headshot
YS

Yevgeniy Eugene Shildkrot

Associate Professor
Unit: School of Medicine
Department: Department of Ophthalmology
Office location and address
UVA Medical Park Northridge
21 Hospital Dr
Charlottesville, Virginia 22903
Education
M.D., New York School of Medicine, 2004
Resident, Kresge Eye Institute, Wayne State University, Detroit, MI (Ophthalmology)
Fellow, Hamilton Eye Institute University of Tennessee Health Science Center and St. Jude Children's Research Hospital (Ocular Oncology)
Fellow, Massachusetts Eye and Ear Infirmary, Harvard Medical School (Vitreoretinal Diseases and Surgery)
Biography

Eugene Shildkrot, MD, is an ophthalmologist specializing in rare ocular and periocular cancers. He also specializes in complex and unusual medical and surgical vitreoretinal diseases. He is a founding member of the University of Virginia’s pediatric and adult ocular oncology service and serves as the quality officer for the Department of Ophthalmology. He is an assistant professor and is board-certified in ophthalmology.

Dr. Shildkrot was born in Belarus, moving to New York City during high school. He completed his undergraduate studies at Cornell University and earned his medical degree at New York University School of Medicine. Dr. Shildkrot completed his residency in ophthalmology at Wayne State University’s Kresge Eye Institute. His fellowship in ocular oncology took place at the University of Tennessee Health Science Center’s Hamilton Eye Institute and St. Jude Children's Research Hospital. He completed an additional fellowship in vitreoretinal diseases and surgery at Harvard Medical School’s Massachusetts Eye and Ear Infirmary. He joined the faculty at the University of Virginia in 2012.

MD-OPHT: Chengdu Kanghong Wet AMD
Source: Syneos Health, LLC
August 26, 2019 – August 25, 2022
CLEAR II- DecisionDx-Uveal Melanoma (UM) 15-Gene Expression Profile Test Clinical Impact Study
Source: Castle Biosciences, Inc.
August 13, 2018 – August 12, 2021
MD-OPHT Shildkrot Castle Biosciences CLEAR
Source: Castle Biosciences, Inc.
July 27, 2014 – July 27, 2021
MD-OPHTH: Kalvista DME
Source: Ora, Inc.
June 12, 2018 – June 11, 2021
MD-OPHTH:VIDI:DME Study
Source: Astellas Pharma Global Development, Inc.
March 31, 2015 – March 31, 2019
MD-OPHTH: CEDAR; AMD Study
Source: Allergan, Inc.
March 06, 2016 – March 05, 2019
MD-PEDT-National Immunization Project with the APA (NIPA) Wave 3
Source: Academic Pediatrics Association
January 11, 2017 – January 11, 2019
MD-OPHT Shildkrot: Lampz Study
Source: Genentech, Inc
August 14, 2014 – August 14, 2018
MD-OPHTH: Regeneron ONYX Study
Source: Regeneron Pharmaceuticals, Inc.
September 13, 2016 – June 30, 2017
MD-OPHT Bayer Dream Study
Source: Syneos Health, LLC
December 01, 2015 – November 30, 2016
MD-OPHTH GSK Dry AMD
Source: GlaxoSmithkline Beecham Pharmaceuticals
August 12, 2011 – December 31, 2015